Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1498 related articles for article (PubMed ID: 26715812)

  • 1. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
    Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
    Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with early recurrence after curative surgery for gastric cancer.
    Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
    World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is D2 lymphadenectomy in gastrectomy safe with regard to the skill of the operator?
    Moriwaki Y; Kobayashi S; Kunisaki C; Harada H; Imai S; Kido Y; Kasaoka C
    Dig Surg; 2001; 18(2):111-7. PubMed ID: 11351155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open vs robot-assisted laparoscopic gastric resection with D2 lymph node dissection for adenocarcinoma: a case-control study.
    Caruso S; Patriti A; Marrelli D; Ceccarelli G; Ceribelli C; Roviello F; Casciola L
    Int J Med Robot; 2011 Dec; 7(4):452-8. PubMed ID: 21984205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer?
    Eom BW; Joo J; Kim YW; Park B; Park JY; Yoon HM; Lee JH; Ryu KW
    Ann Surg Oncol; 2013 Aug; 20(8):2669-75. PubMed ID: 23543195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
    Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
    Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective observational study of 468 patients undergoing D2 or D3 lymphadenectomy for gastric cancer.
    Bostanci EB; Ozer I; Ercan M; Ulas M; Koc U; Karaman K; Dalgic T; Ozogul Y; Akoglu M
    Hepatogastroenterology; 2013 May; 60(123):624-7. PubMed ID: 23635437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascularizing lymph node dissection for advanced gastric cancer: A single-institution experience.
    Han FH; Zhou SN; Li HM; He YL; Zhan WH
    World J Gastroenterol; 2016 Apr; 22(14):3813-20. PubMed ID: 27076766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Low Weight Affects Long-term Outcomes Following Curative Gastrectomy for Gastric Cancer.
    Komatsu S; Kosuga T; Kubota T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    Anticancer Res; 2018 Sep; 38(9):5331-5337. PubMed ID: 30194185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of complication grade on survival following curative gastrectomy for carcinoma.
    Jiang N; Deng JY; Ding XW; Zhang L; Liu HG; Liang YX; Liang H
    World J Gastroenterol; 2014 Jul; 20(25):8244-52. PubMed ID: 25009399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic D2 Lymph Node Dissection During Distal Subtotal Gastrectomy for Gastric Cancer: Toward Procedural Standardization.
    Kim YM; Son T; Kim HI; Noh SH; Hyung WJ
    Ann Surg Oncol; 2016 Aug; 23(8):2409-10. PubMed ID: 26957501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical and long-term oncologic outcomes of laparoscopic and open gastrectomy for serosa-positive (pT4a) gastric cancer: A propensity score-matched analysis.
    Li Z; Liu Y; Hao Y; Bai B; Yu D; Zhao Q
    Surg Oncol; 2019 Mar; 28():167-173. PubMed ID: 30851895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.